Companies in the news after the bell Tuesday.» Read More
NEW YORK-- Shares of Allscripts Healthcare Solutions Inc. continued to rise Monday as Wall Street evaluated a report that the electronic health records company may sell itself to a private buyer. THE SPARK: Bloomberg News reported Friday that Allscripts is considering a sale and had engaged Citigroup Inc. as it considered its options.
Looking for trades that are about to heat up? Summer may be the right season for the following 4 stocks.
Given tech’s market leadership this year and the emerging comparisons to the crisis of several years ago, we rounded up the 10 best performance tech ETFs over the past three years.
Today's modest market rise was powered by Amazon, Expedia and Cerner. But for those who missed the surge, Mad Money host Jim Cramer, says it might still be a buying opportunity.
Human Genome Sciences is one of the reasons the NYSE Arca Biotech Index is having its best day since December 2010.
We may still be listening to Madonna today – who topped the charts with “Like a Prayer” in 1989 – but time has not stood still for your money.
Cramer makes the call on viewers' favorite stocks.
Here's our Fast Money Final Trade. Our gang gives you tomorrow's best trades, right now!
It's the basic question when investing in a stock: is it on the way up or will it go down? Wall Street has developed numerous ways of attempting to predict what will happen.
The “Mad Money” host admits he made a mistake, and now recommends a different name in the health care information technology wars.
Mad Money's Cramer explains why the best way to play the expansion of electronic medical records is to sell Allscripts and swap into Cerner, the next time the stock gets pulled down with the rest of the market.
Technology stocks have been gaining momentum in 2012, up eight of the last nine weeks. However, over the last 12 months, consumer discretionary and health care companies have really powered the rally.
Caesars Entertainment is among several companies showing unusual movement in Wednesday's trading session.
When it comes to combating financial markets that all seem to move in unison, the options are getting so limited that some are questioning whether stock picking is a dying art.
Expected government cuts to Medicare and Medicaid, the uncertainty of health care reform and looming patent expirations are weighing heavily on the outlook of the biggest companies in the sector: large-cap pharmaceutical stocks.
The "Mad Money" host also talks Cerner, Allscripts and Wabco
We ran out of time on TV, but we didn't forget. Click here for our Fast Money Final Trades.
With the bull market in its second year and with volatility picking up, the "Fast" traders said it's time to turn away from buying blind and switch into stock-picker mode.
Here's why you should keep a close eye on these six stocks.
See what's happening, who's talking and what will be making headlines on Wednesday's Squawk on the Street.